Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma-Reference-Cited by-同舟云学术

Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma

Published:2015-03 Issue:3 Volume:39 Page:383-393
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Gronchi Alessandro,Collini Paola,Miceli Rosalba,Valeri Barbara,Renne Salvatore L.,Dagrada Gianpaolo,Fiore Marco,Sanfilippo Roberta,Barisella Marta,Colombo Chiara,Morosi Carlo,Stacchiotti Silvia,Casali Paolo G.,Dei Tos Angelo P.,Pilotti Silvana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference32 articles.

1. . Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.;Dalal;Ann Surg,2006

2. . Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.;Dei Tos;J Pathol,2000

3. . Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.;Pilotti;J Pathol,1998

4. . HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.;Italiano;Int J Cancer,2008

5. . Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.;Crago;Clin Cancer Res,2012

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruptions in antigen processing and presentation machinery on sarcoma;Cancer Immunology, Immunotherapy;2024-09-09

2. Soft Tissue Fine-Needle Aspiration;Surgical Pathology Clinics;2024-09

3. The association between CD34 expression status and the clinicopathological behavior of dedifferentiated liposarcoma;Pathology - Research and Practice;2024-08

4. Impact of disruptions in antigen processing and presentation machinery on sarcoma;2024-07-12

5. Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report;ESMO Open;2024-07